Related Experiment Video
Updated: Jul 23, 2026

A Model of Glaucoma Induced by Circumlimbal Suture in Rats and Mice
Published on: October 5, 2018
Necessity of the Honan intraocular pressure reducer in cataract surgery using topical anesthesia
E H Black1, K L Cohen, N K Tripoli
1Department of Ophthalmology, University of North Carolina at Chapel Hill, USA.
Insights
The Honan intraocular pressure reducer (HIPR) temporarily lowered eye pressure before cataract surgery. However, this effect was short-lived, offering no sustained benefit when using topical anesthesia.
Area of Science:
- Ophthalmology
- Surgical Innovation
- Patient Outcomes
Background:
- Cataract surgery requires careful management of intraocular pressure (IOP).
- The Honan intraocular pressure reducer (HIPR) is a device designed to lower IOP.
- Assessing the efficacy of HIPR in conjunction with topical anesthesia for clear corneal cataract surgery is crucial.
Purpose of the Study:
- To evaluate the effectiveness of the Honan intraocular pressure reducer (HIPR) in reducing intraocular pressure (IOP) during clear corneal cataract surgery performed with topical anesthesia.
Main Methods:
- A randomized controlled trial was conducted with 51 patients undergoing cataract surgery.
- 26 patients were assigned to the HIPR group, wearing the device for 10 minutes pre-surgery.
- Intraocular pressure (IOP) was measured at three time points: pre-HIPR (T1), post-HIPR (T2), and pre-surgery (T3).
Main Results:
- The HIPR group showed a significant IOP reduction between T1 and T2 (P = 2.8 x 10(-7)).
- Mean IOP in the HIPR group returned to baseline levels by T3, showing a significant increase from T2 (P = 3.5 x 10(-9)).
- No significant difference in IOP was observed between the HIPR and control groups at T1 and T3.
Conclusions:
- The Honan intraocular pressure reducer (HIPR) provides a transient reduction in intraocular pressure (IOP) when used with topical anesthesia.
- The IOP-lowering effect of the HIPR dissipates before the commencement of cataract surgery.
- The study concludes that the HIPR does not offer a sustained IOP benefit for cataract surgery under topical anesthesia.
Purpose:
To assess the use of the Honan intraocular pressure reducer (HIPR) for clear corneal cataract surgery using topical anesthesia.
Setting:
University of North Carolina Hospitals Ambulatory Care Clinic outpatient operating rooms.
Methods:
Of 51 consecutive candidates for surgery (excluding those with uncontrolled glaucoma), 26 were randomly assigned to wear the HIPR (Honan group) for 10 minutes before surgery. The remainder were placed in a control group. Intraocular pressure (IOP) was measured before (T1) and after (T2) HIPR application and after patient preparation for surgery (T3).
Results:
Mean IOP was the same in the Honan and control groups at T1 and T3. At T2, the groups had a significantly different mean IOP (P = 1.8 x 10(-5)). In the Honan group, mean IOP decreased significantly (P = 2.8 x 10(-7)) between T1 and T2, and there was a significant correlation among patients at T1 and T2 (P < .0005). Between T2 and T3, the Honan group experienced a significant recovery (P = 3.5 x 10(-9)); there was a significant correlation between the decreases from T1 to T2 and the increases from T2 to T3 (P < .0005). Mean IOP in the control group did not change between T1 and T2 but increased significantly between T2 and T3 (P = .004).
Conclusion:
When using topical anesthesia, the HIPR transiently reduced IOP. However, the IOP-reducing effect resolved by the time of surgery, negating any reason to use the HIPR with topical anesthesia for cataract surgery.
Related Concept Videos
Glaucoma: Overview
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Local Anesthetics: Common Agents and Their Applications
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
Ophthalmic Drug Delivery Systems

